Holly Goe, a registered nurse, has been named vice president of Indiana University Health Cancer Centers, a large group of oncologists that is part of the IU Health hospital network. Goe has been serving as interim vice president since October after being named the program’s executive director for clinical operations last April. Goe will work with Dr. Doug Schwartzentruber, the medical director for cancer services at IU Health, to retool how the entire IU Health system manages cancer patients. Before coming to IU Health last year, Goe worked at the University of Pittsburgh Medical Center in Pittsburgh, Pa., and before that, worked at Parkview Health in Fort Wayne.

Dr. Douglas Wallace, a cardiothoracic surgeon, has joined St. Vincent Medical Group in Lafayette. He earned his bachelor’s degree in biochemistry from the University of California,Davis, and his medical degree from Uniformed Services University of Health Sciences in Bethesda, Md.

The Indiana University Melvin and Bren Simon Cancer Center has added six new researchers: Dr. Gary Dunnington, who studies surgery outcomes for breast cancer patients; Reginald Hill, a researcher who studies how inflammation contributes to pancreatic cancer; Janaiah Kota, who studies the role of micro RNAs (ribonucleic acids) in cancers and develops microRNA-based cancer drugs; Dr. Sophie Paczesny, who studies complications from bone marrow transplants; Jenifer Prosperi, who studies breast cancer development; and Dr. Chandru Sundaram, whose research focuses on the outcomes of laparoscopic and robotic surgery for kidney and prostate cancers.